← Leaderboards
Michael F Tweedle
Ohio State University
$1,876,823
Attributed
$4,337,609
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2016–23$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,337,609 · 2
By mechanism
R01$2,337,609 · 1
R44$2,000,000 · 1
Top collaborators
- Michael V Knopp4 shared
- Thomas J Rosol3 shared
- Songqi Gao1 shared
- Yajuan Li1 shared
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingCanis FamiliarisPet/Ct ScanMalignant Neoplasm Of ProstateDiagnosisTumorImage GuidedImagePeptidesMonitorProtocols DocumentationProstate Cancer CellClinical TrialsTissuesDoseDrug KineticsHigh RiskBindingIn VivoPharmacologyAdverse EffectsBaseArterial EmbolizationComplement
Grant awards (6)
Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer$1,000,000
R44 · FY2023 · CA
Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer$1,000,000
R44 · FY2022 · CA
Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer$585,719
R01 · FY2019 · EB · contact PI
Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer$585,719
R01 · FY2018 · EB · contact PI
Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer$584,236
R01 · FY2017 · EB · contact PI
Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer$581,935
R01 · FY2016 · EB · contact PI